A Centers for Disease Control and Prevention panel is meeting today to weigh the risks versus the benefits of COVID-19 vaccinations for young adults after reports of heart inflammation among a small number of teen vaccine recipients.
The CDC and the Food and Drug Administration had confirmed – as of June 14 – 323 cases of myocarditis, inflammation of the heart muscle, or pericarditis, inflammation of the sac that surrounds the heart, in people younger than 30 who had received either the Pfizer or Moderna vaccines. That’s out of more than 310 million doses administered in the U.S.
The Advisory Committee on Immunization Practices said in May that the “relatively few” reports of myocarditis “appear to be mild”
